1. Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients. (3rd March 2023) Authors: Elsaka, Rasha; Kitagwa, Joan Minyika; Refaat, Tamer; Mahmoud, Amr A.; Shaikh, Hamza; Meheissen, Mohamed A.M.; Elsaid, Amr Abdelaziz Journal: American journal of clinical oncology Issue: Volume 46:Number 3(2023) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗